Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis

Neuroscience

Volumn 189, Issue , 2011, Pages 286-292

  Nishioku, T ^a   Furusho, K ^a   Tomita, A ^a   Ohishi, H ^a   Dohgu, S ^a   Shuto, H ^a   Yamauchi, A ^a   Kataoka, Y ^a,b  

^a FUKUOKA UNIVERSITY   (Japan)

^b PharmaCo Cell Co Ltd   (Japan)

Author keywords

Blood brain barrier; Collagen induced arthritis; Occludin; P53; Rheumatoid arthritis; S100A4

Indexed keywords

CALVASCULIN; COLLAGEN TYPE 2; FLUORESCEIN SODIUM; OCCLUDIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; UPREGULATION;

EID: 79960927426     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.05.044     Document Type: Article

References (38)

1. Abbott N., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
2. Ambartsumian N., Klingelhofer J., Grigorian M., Christensen C., Kriajevska M., Tulchinsky E., Georgiev G., Berezin V., Bock E., Rygaard J., Cao R., Cao Y., Lukanidin E. The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 2001, 20:4685-4695.
3. Arosio E., De Marchi S., Rigoni A., Prior M., Delva P., Lechi A. Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens 2007, 25:1273-1278.
4. Bauer A.T., Burgers H.F., Rabie T., Marti H.H. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 2010, 30:837-848.
5. Bazzoni G., Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004, 84:869-901.
6. Belot N., Pochet R., Heizmann C.W., Kiss R., Decaestecker C. Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. Biochim Biophys Acta 2002, 1600:74-83.
7. Brooks T., Hawkins B., Huber J., Egleton R., Davis T. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol 2005, 289:H738-H743.
8. Dehouck M.P., Jolliet-Riant P., Bree F., Fruchart J.C., Cecchelli R., Tillement J.P. Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. J Neurochem 1992, 58:1790-1797.
9. Deli M.A., Joo F., Krizbai I., Lengyel I., Nunzi M.G., Wolff J.R. Calcium/calmodulin-stimulated protein kinase II is present in primary cultures of cerebral endothelial cells. J Neurochem 1993, 60:1960-1963.
10. Galarraga B., Khan F., Kumar P., Pullar T., Belch J. C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford) 2008, 47:1780-1784.
11. Hawkins B., Davis T. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005, 57:173-185.
12. Helfman D., Kim E., Lukanidin E., Grigorian M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 2005, 92:1955-1958.
13. Hirase T., Staddon J.M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S., Rubin L.L. Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 1997, 110(Pt 14):1603-1613.
14. Huang W., Eum S.Y., Andras I.E., Hennig B., Toborek M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J 2009, 23:1596-1606.
15. Huber J., Hau V., Mark K., Brown R., Campos C., Davis T. Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant. Eur J Pharmacol 2002, 450:297-304.
16. Huber J., Witt K., Hom S., Egleton R., Mark K., Davis T. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol 2001, 280:H1241-H1248.
17. Huppert J., Closhen D., Croxford A., White R., Kulig P., Pietrowski E., Bechmann I., Becher B., Luhmann H.J., Waisman A., Kuhlmann C.R. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 2010, 24:1023-1034.
18. Kerekes G., Szekanecz Z., Dér H., Sándor Z., Lakos G., Muszbek L., Csipö I., Sipka S., Seres I., Paragh G., Kappelmayer J., Szomják E., Veres K., Szegedi G., Shoenfeld Y., Soltész P. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008, 35:398-406.
19. Klingelhöfer J., Senolt L., Baslund B., Nielsen G., Skibshøj I., Pavelka K., Neidhart M., Gay S., Ambartsumian N., Hansen B., Petersen J., Lukanidin E., Grigorian M. Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2007, 56:779-789.
20. Maradit-Kremers H., Crowson C., Nicola P., Ballman K., Roger V., Jacobsen S., Gabriel S. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005, 52:402-411.
21. Masuda K., Masuda R., Neidhart M., Simmen B., Michel B., Müller-Ladner U., Gay R., Gay S. Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. Arthritis Res 2002, 4:R8.
22. Nadareishvili Z., Michaud K., Hallenbeck J., Wolfe F. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008, 59:1090-1096.
23. Nishioku T., Dohgu S., Takata F., Eto T., Ishikawa N., Kodama K.B., Nakagawa S., Yamauchi A., Kataoka Y. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell Mol Neurobiol 2009, 29:309-316.
24. Nishioku T., Yamauchi A., Takata F., Watanabe T., Furusho K., Shuto H., Dohgu S., Kataoka Y. Disruption of the blood-brain barrier in collagen-induced arthritic mice. Neurosci Lett 2010, 482:208-211.
25. Oslejskova L., Grigorian M., Hulejova H., Vencovsky J., Pavelka K., Klingelhofer J., Gay S., Neidhart M., Brabcova H., Suchy D., Senolt L. Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis. Rheumatology (Oxford) 2009, 48:1590-1594.
26. Rigau V., Morin M., Rousset M.C., de Bock F., Lebrun A., Coubes P., Picot M.C., Baldy-Moulinier M., Bockaert J., Crespel A., Lerner-Natoli M. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007, 130:1942-1956.
27. Schmidt-Hansen B., Klingelhöfer J., Grum-Schwensen B., Christensen A., Andresen S., Kruse C., Hansen T., Ambartsumian N., Lukanidin E., Grigorian M. Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay. J Biol Chem 2004, 279:24498-24504.
28. Schmidt-Hansen B., Ornås D., Grigorian M., Klingelhöfer J., Tulchinsky E., Lukanidin E., Ambartsumian N. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004, 23:5487-5495.
29. Schubert-Unkmeir A., Konrad C., Slanina H., Czapek F., Hebling S., Frosch M. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog 2010, 6:e1000874.
30. Senolt L., Grigorian M., Lukanidin E., Michel B., Gay R., Gay S., Pavelka K., Neidhart M. S100A4 (Mts1): is there any relation to the pathogenesis of rheumatoid arthritis?. Autoimmun Rev 2006, 5:129-131.
31. Sumi N., Nishioku T., Takata F., Matsumoto J., Watanabe T., Shuto H., Yamauchi A., Dohgu S., Kataoka Y. Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia. Cell Mol Neurobiol 2010, 30:247-253.
32. Ueno M., Wu B., Nishiyama A., Huang C., Hosomi N., Kusaka T., Nakagawa T., Onodera M., Kido M., Sakamoto H. The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model. Hypertens Res 2009, 32:332-338.
33. Van Doornum S., McColl G., Jenkins A., Green D., Wicks I. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 2003, 48:72-80.
34. Vaudo G., Marchesi S., Gerli R., Allegrucci R., Giordano A., Siepi D., Pirro M., Shoenfeld Y., Schillaci G., Mannarino E. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004, 63:31-35.
35. Wolfe F., Mitchell D., Sibley J., Fries J., Bloch D., Williams C., Spitz P., Haga M., Kleinheksel S., Cathey M. The mortality of rheumatoid arthritis. Arthritis Rheum 1994, 37:481-494.
36. Yan J., Chen C., Hu Q., Yang X., Lei J., Yang L., Wang K., Qin L., Huang H., Zhou C. The role of p53 in brain edema after 24 h of experimental subarachnoid hemorrhage in a rat model. Exp Neurol 2008, 214:37-46.
37. Zibert J.R., Skov L., Thyssen J.P., Jacobsen G.K., Grigorian M. Significance of the S100A4 protein in psoriasis. J Invest Dermatol 2010, 130:150-160.
38. Zlokovic B. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.